Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diagnostics (Basel, Switzerland)|October 21, 2020
Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological BiomarkersCleo Keppens, Ed Schuuring, Elisabeth Mc Dequeker
Virchows Archiv : an International Journal of Pathology|November 23, 2020
Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveysCleo Keppens, Ed Schuuring, Elisabeth M C Dequeker
The Journal of Molecular Diagnostics : JMD|April 7, 2018
External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker TestingKelly Dufraing, Gert De Hertogh, Véronique Tack, et al.
Virchows Archiv : an International Journal of Pathology|December 4, 2020
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretationCleo Keppens, Elisabeth Mc Dequeker, Patrick Pauwels, et al.
Human Mutation|September 26, 2019
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?Cleo Keppens, Véronique Tack, Kelly Dufraing, et al.
British Journal of Cancer|August 25, 2018
Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratoriesVéronique Tack, Ed Schuuring, Cleo Keppens, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2019
European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projectsCleo Keppens, Kelly Dufraing, Han J van Krieken, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2020
Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung CancerCleo Keppens, Jan von der Thüsen, Patrick Pauwels, et al.
Pageof 2